Double Check of Long Acting Insulin by Nursing Staff Drawn Up by Pharmacy

PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.

4 posts / 0 new

Last post

Thu, 04/25/2019 - 09:41

Ruth LaCasse Kalish

Offline

Last seen: 5 years 7 months ago

Joined: 12/12/2014 - 11:35

Double Check of Long Acting Insulin by Nursing Staff Drawn Up by Pharmacy

Hi members,

We are evaluating our policy on double check of insulin products. We had converted to pharmacy drawing up Lantus and other long acting insulin products in our IV room using camera compounding technology but a double check still remains for nursing on all insulin. This double check (long-acting insulin products excluding U500 as separate policy) is mainly to ensure the syringe is appropriate for the patient and it is drawn up to the correct dose however they have no vial to compare to. Has anyone removed or not have a double check on insulin drawn up by pharmacy? If no double check, any other practices in place to prevent any insulin errors and keep a high alert status. Feel free to respond if you have a practice such as ours and have not removed the double check for long acting insulin products. We do not plan to change the double check for our short acting insulin products at this time.

Thank you for any information,
Ruth

Members Log In